PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Midazolam hydrochloride (Buccolam) - Status epilepticus
PAD Profile : Midazolam hydrochloride (Buccolam) - Status epilepticus
Keywords :
midazolam oral solution, midazolam oromucosal solution, midazolam buccal, buccal midazolam
Brand Names Include :
Buccolam
Traffic Light Status
Status 1 of 3.
Status :
Blue
Important
Preferred
Formulations :
- Pre-filled oral syringe
Important Information :
Prescribe by BRAND. Buccolam is currently the preferred, lower-cost in patients over 3 months of age
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Red
Important
Important Information :
Unlicensed preparations / specials have a Red traffic light status - not for prescribing in primary care.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
03 April 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Status Epilepticus in all age groups (over 3 months of age)
The Surrey Heartlands Area Prescribing Committee agreed that:
- Buccolam (midazolam hydrochloride) and Epistatus (midazolam maleate) will be assigned a Blue traffic light status (no information sheet required) for all ages over 3 months of age when used for Status Epilepticus.
- Buccolam and Epistatus should be prescribed by brand (in line with MHRA & NICE guidance) https://surreyccg.res-systems.net/PAD/Guidelines/Detail/5045
- The least costly preparation should be used at the point of initiation (currently Buccolam - April 2024)
NOTE: the use of Buccolam and Epistatus in patients aged 18 years and over is off-label.
Unlicensed specials will be assigned a RED traffic light status.
Patients using unlicensed preparations should be reviewed for a potential switch to the licensed product following liaison with their specialist.
Associated BNF Codes
04. Central Nervous System
04.08.02. Drugs used in status epilepticus